Role of novel hematological biomarkers in assessing chronic obstructive pulmonary disease (COPD) patients and their public health implications.

Patel T, Singh G, Rachani K, Dangar A, Deokar K, Joshi K, Shukla D

Open source

DOI
10.4103/jfmpc.jfmpc_1301_25
Published
2026 Feb
Container
Journal of family medicine and primary care
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4103/jfmpc.jfmpc_1301_25,
  title = {Role of novel hematological biomarkers in assessing chronic obstructive pulmonary disease (COPD) patients and their public health implications.},
  author = {Patel T and Singh G and Rachani K and Dangar A and Deokar K and Joshi K and Shukla D},
  year = {2026},
  journal = {Journal of family medicine and primary care},
  doi = {10.4103/jfmpc.jfmpc_1301_25},
  url = {https://doi.org/10.4103/jfmpc.jfmpc_1301_25}
}

RIS

TY  - JOUR
TI  - Role of novel hematological biomarkers in assessing chronic obstructive pulmonary disease (COPD) patients and their public health implications.
AU  - Patel T
AU  - Singh G
AU  - Rachani K
AU  - Dangar A
AU  - Deokar K
AU  - Joshi K
AU  - Shukla D
PY  - 2026
JO  - Journal of family medicine and primary care
DO  - 10.4103/jfmpc.jfmpc_1301_25
UR  - https://doi.org/10.4103/jfmpc.jfmpc_1301_25
ER  - 

APA

T, P., G, S., K, R., A, D., K, D., K, J., & D, S. (2026). Role of novel hematological biomarkers in assessing chronic obstructive pulmonary disease (COPD) patients and their public health implications.. Journal of family medicine and primary care. https://doi.org/10.4103/jfmpc.jfmpc_1301_25

Source records